Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA Urges Tighter Controls on Certain Prescription Painkillers
Changes would decrease number of refills before returning to doctor; supplies lasting ≤90 days

THURSDAY, Oct. 24 (HealthDay News) -- On Thursday, the U.S. Food and Drug Administration called for tighter controls on prescription painkillers containing the narcotic hydrocodone.

The action comes after years of disagreement over how much leeway doctors should have in prescribing the often-abused drugs. The New York Times reported that the move indicates a major policy shift on drugs including Vicodin, Lortab, or generics that combine hydrocodone with over-the-counter pain medicines like aspirin or acetaminophen.

Currently, hydrocodone painkillers are less tightly monitored than more powerful painkillers such as OxyContin, the Times noted. The FDA-proposed changes would decrease the number of refills patients could receive before returning to their doctor, with supplies lasting 90 days at the most. Doctors would not be able to call in refills -- patients would have to take prescriptions to the pharmacy in person.

The regulations would go into effect after approval from the U.S. Department of Health and Human Services. The U.S Drug Enforcement Agency has pushed for the new recommendation, while some medical groups and pharmacy organizations have opposed it because of the effect on patients, the Times reported.

More Information



Copyright © 2013 HealthDay. All rights reserved.

October 2, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

In Cancer Prevention, 9-Valent HPV Vaccine Looks Promising

No Genetic Proof Vitamin D Guards Against Type 2 Diabetes

CDC Issues Ebola Best Practices Reminder for Providers

CDC Monitoring Those Who Had Contact With Ebola Patient

ESICM: Transfusion Threshold Not Major Factor in Sepsis Outcomes

Social Support May Be Key to Heart Attack Recovery